Pheon Therapeutics
London
About Pheon Therapeutics
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. The company was founded in 2022 and is based in London, England.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $188.0M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2024)
- Website: pheontx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pheon-therapeutics-84872 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.